Eternygen GmbH

📍 Berlin, Germany🗓 Founded 2012👥 7 employees💰 Last funded Jan 2017
Biotechnology Research🌐 eternygen.com
Website LinkedIn
Eternygen is a Berlin based start up founded in June 2012 focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations. The main focus of Eternygen´s development and core competences of its founders are research and development of new drugs for dietary-related metabolic diseases with dramatically increasing prevalences in the last decades. Eternygen´s research addresses the sodium coupled citrate transporter NaCT which is a key regulator of lipid metabolism involved in the pathogenesis of fatty liver, diabetes and obesity. Company´s emphasis is the development of a safe and effective drug for treatment of these widespread diseases via targeted adjustment of underlying metabolic failure.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Eternygen GmbH?
Eternygen GmbH has 1 investors on record on gritt.io, 1 mid-stage.
When did Eternygen GmbH last raise funding?
The most recent investment in Eternygen GmbH recorded on gritt.io was in January 2017.
When was Eternygen GmbH founded?
Eternygen GmbH was founded in 2012.
What industry is Eternygen GmbH in?
Eternygen GmbH operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Eternygen GmbH based?
Eternygen GmbH is headquartered in Berlin, Germany.